Raymond James Financial
CNMD icon

Raymond James Financial’s CONMED CNMD Stock Holding History

Raymond James Financial’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Sell
84,526
-2,612
-3% -$94K ﹤0.01% 3245
2026
Q1 		$3.08M Sell
87,138
-57,175
-40% -$2.33M ﹤0.01% 2994
2025
Q4 		$5.86M Sell
144,313
-28,578
-17% -$1.24M ﹤0.01% 2389
2025
Q3 		$8.13M Sell
172,891
-121,054
-41% -$6.28M ﹤0.01% 2089
2025
Q2 		$15.3M Sell
293,945
-96,730
-25% -$5.31M 0.01% 1558
2025
Q1 		$23.6M Buy
390,675
+124,050
+47% +$8M 0.01% 1182
2024
Q4 		$18.2M Buy
+266,625
New +$18.6M 0.01% 1397

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Raymond James Financial's CNMD Position: Q2 2026 in Review

Raymond James Financial reduced its CONMED (CNMD) stake by 3% in Q2 2026, selling an estimated $94K and leaving 84,526 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #3245.

Raymond James Financial first reported a position in CNMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $23.6M in Q1 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Raymond James Financial held 84,526 shares of CONMED worth $2.77M as of Q2 2026.
  • Raymond James Financial sold 2,612 CONMED shares in Q2 2026, an estimated $94K.
  • CONMED made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3245 holding.
  • Raymond James Financial first reported a position in CONMED in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's CONMED position peaked at $23.6M in Q1 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.